Polymorph of a Pharmaceutical
AssigneeAbbott Laboratories
InventorsJohn F. Bauer, Azita Saleki-Gerhardt, Bikshandarkoil A. Narayanan, Sanjay R. Chemburkar, Ketan M. Patel, Harry O. Spiwek, Philip E. Bauer, Kimberly A. Allen
Life of this patent
Estimating the term…
Abstract
A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.
Claims5
A process for preparing a composition comprising ritonavir, said process comprising dissolving Form II crystalline ritonavir in a solvent, wherein said Form II crystalline ritonavir has characteristic peaks in the powder X-ray diffraction pattern at values of two theta of 8.67°±0.1°, 9.88°±0.1°, 16.11°±0.1°, 16.70°±0.1°, 17.36°±0.1°, 17.78°±0.1°, 18.40°±0.1°, 18.93°±0.1°, 20.07°±0.1°, 20.65°±0.1°, 21.71°±0.1° and 25.38°±0.1°.
Dependencies are inferred from the claim text.